Patient Guide: A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 157 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04008030
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Colorectal Cancer
Phase: PHASE3

Where You Can Participate

This study is available at 157 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Sacramento, California
  • • Denver, Colorado
  • • And 154 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC) - Join Clinical Trial NCTNCT04008030

How to Join This Clinical Trial - NCTNCT04008030

Learn how to participate in this PHASE3 trial studying an investigational therapy for Metastatic Colorectal Cancer. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Metastatic Colorectal Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Metastatic Colorectal Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04008030 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 157 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90033 - United States

Status: Contact for availability

Clinical Research Site

Sacramento, California 95817 - United States

Status: Contact for availability

Clinical Research Site

Denver, Colorado 80218 - United States

Status: Contact for availability

Clinical Research Site

Arlington Heights, Illinois 60005 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10065 - United States

Status: Contact for availability

Clinical Research Site

Portland, Oregon 97227 - United States

Status: Contact for availability

Clinical Research Site

Pittsburgh, Pennsylvania 15232 - United States

Status: Contact for availability

Clinical Research Site

Dallas, Texas 75246 - United States

Status: Contact for availability

Clinical Research Site

Roanoke, Virginia 24014 - United States

Status: Contact for availability

Clinical Research Site

Ciudad Autonoma Beunos Aires, Buenos Aires 1431 - Argentina

Status: Contact for availability

And 147 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Metastatic Colorectal Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships